REG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Result of Annual Meeting

Mycelx TechnologiesAnnouncement

13/07/2022 16:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220713:nRSM3887Sa&default-theme=true

RNS Number : 3887S  MyCelx Technologies Corporation  13 July 2022

13 July 2022

 

 

MYCELX Technologies Corporation

 

("MYCELX" or the "Company") (AIM: MYX or MYXR)

 

Result of Annual Meeting

 

 

The Company is pleased to announce that, at its Annual Meeting held on 13 July
2022 at the offices of Canaccord Genuity, 88 Wood Street, London, EC2V 7QR,
the resolutions set out in the Notice of Annual Meeting were duly passed on a
Poll.

 

Full details of the resolutions passed are set out in the Notice of Meeting
which is available on the Company's website www.mycelx.com
(http://www.mycelx.com) .

 

 Resolutions                                                                 For / Discretion       Against       Total        Vote withheld*
                                                                             Number      %          Number  %
 1A To elect Tom Lamb as a Director                                          12,269,986                           12,269,986   -

                                                                                         100.00     -       -
 1B To elect Connie Mixon as a Director                                      12,269,986                           12,269,986   -

                                                                                         100.00     -       -

 1C To elect Haluk (Hal) Alper as a Director                                 12,269,986             -       -     12,269,986   -

                                                                                         100.00
 1D To elect Andre Schnabl as a Director                                     12,269,986             -       -

                                                                                         100.00                   12,269,986   -

 2. Ratification of appointment of Deloitte & Touche LLP as independent      12,269,986             -       -     12,269,986   -
 registered public accounting firm

                                                                                       100.00

 

*'Vote withheld' is not a vote in law and is not counted in the calculation of
the proportion of the votes 'For' and 'Against' a resolution.

 

For further information please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                             Tel: +1 888 306 6843

 Kim Slayton, CFO

 Canaccord Genuity Limited (Nomad and broker)  Tel: +44 20 7523 8150

 Henry Fitzgerald-O'Connor

 Gordon Hamilton

 Celicourt

 Mark Antelme                                  Tel: +44 20 8434 2754

 Jimmy Lea

 

Notes to Editors

Through its revolutionary patented water technology with a mission to reduce
the impact of industry on the environment, MYCELX brings its customers
material benefits in terms of supporting environmental goals, performance
enhancement, cost savings and small footprint. Working beyond any ordinary
filtration methods, MYCELX's proprietary technology achieves oil removal to
less than one part per million as well as removal of other emerging
contaminants in water streams. MYCELX supports its international customers
across the oil & gas value chain by ensuring clean water discharge or
reuse and in groundwater remediation for industrial and military sites. MYCELX
also provides advanced air filtration technology for manufacturing and
industrial facilities, effectively removing oil particles and biologicals to
maintain continuous and safe air quality levels.

For more information, visit www.MYCELX.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGBKNBBQBKDFOD